| |
 |
|
Class Information
Number: 514/209
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > 1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) > Alkyl, hydroxyalkyl, alkoxyalkyl, or alkanoyloxyakyl bonded directly to 3-position
Description: Subject matter wherein alkyl, alkyl-OH, alkyl-O-alkyl, alkyl-C(=O)-O-alkyl is bonded directly to 3-position of the bicyclo octane ring system.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7476650 |
Enzyme inhibition |
Jan. 13, 2009 |
| 7185647 |
Determination of smoothness of canisters containing inhalable medicaments |
Mar. 6, 2007 |
| 7094431 |
Method of healing skin wounds in mammals and a composition therefor |
Aug. 22, 2006 |
| 6906054 |
Compositions for inhibiting beta-lactamase |
Jun. 14, 2005 |
| 6831099 |
Enzyme inhibition |
Dec. 14, 2004 |
| 6815426 |
Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
Nov. 9, 2004 |
| 6599892 |
7-alkylidene cephalosporanic acid derivatives and methods of using the same |
Jul. 29, 2003 |
| 6489319 |
Neurotherapeutic use of carboxypeptidase inhibitors |
Dec. 3, 2002 |
| 6475522 |
Synthetic polymer compositions containing antibiotics as antidegradants |
Nov. 5, 2002 |
| 6458779 |
Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of the TNF release |
Oct. 1, 2002 |
| 6407091 |
.beta.-lactamase inhibiting compounds |
Jun. 18, 2002 |
| 6337339 |
Methods and compositions for treating infection using optically pure (S)-lomefloxacin |
Jan. 8, 2002 |
| 6303592 |
7-alkylidene cephalosporanic acid derivatives and methods of using the same |
Oct. 16, 2001 |
| 6180621 |
Method and treatment using 1-methylcarbapenem derivatives as an anti-helicobacter pylori agent |
Jan. 30, 2001 |
| 6121255 |
Phloroglucide derivatives and their pharmceutical use |
Sep. 19, 2000 |
| 5994340 |
Azetidinone derivatives as .beta.-lactamase inhibitors |
Nov. 30, 1999 |
| 5760027 |
Use of 7-alkylidene cephalosporins to inhibit elastase activity |
Jun. 2, 1998 |
| 5721229 |
Soluble forms of cephalosporins and treatment of animals |
Feb. 24, 1998 |
| 5681563 |
7-vinylidene cephalosporins and methods of using the same |
Oct. 28, 1997 |
| 5650394 |
Use of urinastatin-like compounds to prevent premature delivery |
Jul. 22, 1997 |
| 5637291 |
Surfactant-free oil-in-water emulsion stabilized by hollow thermoplastic particles |
Jun. 10, 1997 |
| 5629306 |
7-alkylidene cephalosporanic acid derivatives and methods of using the same |
May. 13, 1997 |
| 5597817 |
7-vinylidene cephalosporins and methods of using the same |
Jan. 28, 1997 |
| 5580865 |
2,2-disubstituted cephem sulphones |
Dec. 3, 1996 |
| 5409917 |
Topical treatment of acne with cephalosporins |
Apr. 25, 1995 |
| 5312813 |
Biofilm reduction method |
May. 17, 1994 |
| 5278157 |
Stable cephradine hydrate |
Jan. 11, 1994 |
| 5069899 |
Anti-thrombogenic, anti-microbial compositions containing heparin |
Dec. 3, 1991 |
| 5028601 |
Cephalosporin compounds and antibacterial agents |
Jul. 2, 1991 |
| 4971961 |
Cephalosporin compounds and antibacterial agents |
Nov. 20, 1990 |
| 4943568 |
Cephalosporins |
Jul. 24, 1990 |
| 4931438 |
Fungicides |
Jun. 5, 1990 |
| 4731360 |
Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments |
Mar. 15, 1988 |
| 4729989 |
Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts |
Mar. 8, 1988 |
| 4692441 |
Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities |
Sep. 8, 1987 |
| 4623644 |
Acylation of tirandamycic, streptolic and sorbic acids to cephalosporin and penicillin nuclei |
Nov. 18, 1986 |
| 4605651 |
Antibiotic amino acid derivatives of cephalosporins |
Aug. 12, 1986 |
| 4560553 |
Use of eucalyptol for enhancing skin permeation of bio-affecting agents |
Dec. 24, 1985 |
| 4496561 |
Cephalosporin derivative |
Jan. 29, 1985 |
| 4490370 |
Naphthylglycyl cephalosporin derivatives |
Dec. 25, 1984 |
| 4474780 |
Crystalline cephalosporin |
Oct. 2, 1984 |
| 4455306 |
Method for concentrating .beta.-lactam antibiotic solution |
Jun. 19, 1984 |
| 4444755 |
Treatment for skin disorders |
Apr. 24, 1984 |
| 4425337 |
Adjuvants for rectal delivery of drug |
Jan. 10, 1984 |
| 4415554 |
Treatment for menstrual disorders |
Nov. 15, 1983 |
| 4406896 |
Adjuvants for rectal delivery of drug substances |
Sep. 27, 1983 |
| 4393049 |
Treatment for obesity |
Jul. 12, 1983 |
| 4386070 |
Pharmaceutical compositions endowed with an antibacterial activity and their use in the treatment of infections due to gram-positive and gram-negative pathogens |
May. 31, 1983 |
| 4376767 |
Pyridylmethyl esters of selected bio-affecting carboxylic acids |
Mar. 15, 1983 |
| 4374134 |
Cephalosporin compounds with terminal aminocarboxylic acid groupings and anti-bacterial use thereof |
Feb. 15, 1983 |
|
|
|
